{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:11:36Z","timestamp":1772190696725,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.compbiolchem.2025.108471","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T15:03:46Z","timestamp":1744729426000},"page":"108471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The drug discovery candidate for targeting PARP1 with Onosma. Dichroantha compounds in triple-negative breast cancer: A virtual screening and molecular dynamic simulation"],"prefix":"10.1016","volume":"118","author":[{"given":"Mohamed J.","family":"Saadh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan Hassan","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radhwan Abdul","family":"Kareem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muktesh","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lokesh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.V. Siva","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anurag","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waam Mohammed","family":"Taher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariem","family":"Alwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6542-7230","authenticated-orcid":false,"given":"Mahmood Jasem","family":"Jawad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atheer Khdyair","family":"Hamad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiolchem.2025.108471_bib1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/1871520619666191015103712","article-title":"Anticancer potential of dietary natural products: a comprehensive review","volume":"20","author":"Ahmad","year":"2020","journal-title":"Anticancer. Agents Med. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib2","article-title":"Development of an ancestral DC and TLR4-inducing multi-epitope peptide vaccine against the spike protein of SARS-CoV and SARS-CoV-2 using the advanced immunoinformatics approaches","volume":"39","author":"Aram","year":"2024","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13659-020-00283-9","article-title":"Anticancer properties of lobetyolin, an essential component of radix codonopsis (Dangshen)","volume":"11","author":"Bailly","year":"2021","journal-title":"Nat. Prod. Bioprospect"},{"key":"10.1016\/j.compbiolchem.2025.108471_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22105112","article-title":"PARP power: a structural perspective on PARP1, PARP2, and PARP3 in DNA damage repair and nucleosome remodelling","volume":"22","author":"van Beek","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib5","article-title":"Application of serum SERS technology based on thermally annealed silver nanoparticle composite substrate in breast cancer","volume":"41","author":"Cheng","year":"2023","journal-title":"Photo Photodyn. Ther."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/PPO.0b013e3181cf01eb","article-title":"Poly(ADP-ribose) polymerase inhibitors in triple-negative breast cancer","volume":"16","author":"Comen","year":"2010","journal-title":"Cancer J."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13046-018-0741-3","article-title":"The anti-tumor efficacy of CDK4\/6 inhibition is enhanced by the combination with PI3K\/AKT\/mTOR inhibitors through impairment of glucose metabolism in TNBC cells","volume":"37","author":"Cretella","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","volume":"1263","author":"Dallakyan","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib10","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/ijc.27632","article-title":"Targeted therapy for triple-negative breast cancer: where are we?","volume":"131","author":"Duffy","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.compbiolchem.2025.108471_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: an overview","author":"Ferlay","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.compbiolchem.2025.108471_bib12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s40262-017-0587-4","article-title":"PARP inhibitors in the treatment of triple-negative breast cancer","volume":"57","author":"Geenen","year":"2018","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib13","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1245\/s10434-013-3205-1","article-title":"Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort","volume":"20","author":"Greenup","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib14","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2217\/fon.14.313","article-title":"Olaparib: an oral PARP-1 and PARP-2 inhibitor with promising activity in ovarian cancer","volume":"11","author":"Gunderson","year":"2015","journal-title":"Future Oncol."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1753-0407.2010.00107.x","article-title":"Antidiabetic and antioxidant potential of \u03b2-sitosterol in streptozotocin-induced experimental hyperglycemia","volume":"3","author":"Gupta","year":"2011","journal-title":"J. Diabetes"},{"key":"10.1016\/j.compbiolchem.2025.108471_bib16","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.biopha.2017.08.120","article-title":"IL-1\u03b2-induced NF-\u03baB activation down-regulates miR-506 expression to promotes osteosarcoma cell growth through JAG1","volume":"95","author":"Hu","year":"2017","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4155\/fmc-2016-0113","article-title":"A comprehensive look of poly(ADP-ribose) polymerase inhibition strategies and future directions for cancer therapy","volume":"9","author":"Kumar","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1741-7015-10-25","article-title":"Advances in using PARP inhibitors to treat cancer","volume":"10","author":"Kummar","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.compbiolchem.2025.108471_bib19","first-page":"1216","article-title":"Distribution of seven polyphenols in several medicinal plants of boraginaceae in China","volume":"4","author":"Li","year":"2010","journal-title":"J. Med. Plants Res."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1080\/10717544.2018.1455763","article-title":"Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile","volume":"25","author":"Li","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12951-025-03092-9","article-title":"Recent advances in self-targeting natural product-based nanomedicines","volume":"23","author":"Liu","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib22","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/jpp\/rgae058","article-title":"The mechanism of action of botrychium (Thunb.) Sw. for prevention of idiopathic pulmonary fibrosis based on 1H NMR-based metabolomics","volume":"76","author":"Lou","year":"2024","journal-title":"J. Pharm. Pharm."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib23","doi-asserted-by":"crossref","first-page":"51701","DOI":"10.3788\/COL202018.051701","article-title":"Detection of breast cancer based on novel porous silicon bragg reflector surface-enhanced Raman spectroscopy-active structure","volume":"18","author":"Ma","year":"2020","journal-title":"Chin. Opt. Lett."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ph15060667","article-title":"HDAC inhibitors for the therapy of triple negative breast cancer","volume":"15","author":"Maccallini","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.compbiolchem.2025.108471_bib25","first-page":"1","article-title":"\u03b2-carboline alkaloid harmine induces DNA damage and triggers apoptosis by a mitochondrial pathway: study in silico, in vitro and in vivo","volume":"1","author":"Mota","year":"2020","journal-title":"Int. J. Funct. Nutr."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4048\/jbc.2019.22.e39","article-title":"Druggable molecular targets for the treatment of triple negative breast cancer","volume":"22","author":"Nakhjavani","year":"2019","journal-title":"J. Breast Cancer"},{"key":"10.1016\/j.compbiolchem.2025.108471_bib27","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1158\/1078-0432.CCR-19-3545","article-title":"FDA approval summary: atezolizumab plus paclitaxel protein-bound for the treatment of patients with advanced or metastatic TNBC whose tumors express PD-L1","volume":"26","author":"Narayan","year":"2020","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/1389557521666210712111331","article-title":"Development of natural bioactive alkaloids: anticancer perspective","volume":"22","author":"Patel","year":"2022","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib29","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib31","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib32","first-page":"10","article-title":"Matrix metalloproteinase\/Fas ligand (MMP\/FasL) interaction dynamics in COVID-19: An <em>in silico<\u2009\/em>\u2009study and neuroimmune perspective","author":"Saleki","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.compbiolchem.2025.108471_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/biom9110679","article-title":"Natural products and synthetic analogs as a source of antitumor drugs","volume":"9","author":"Sharifi-Rad","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.compbiolchem.2025.108471_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/oncolo\/oyab053","article-title":"Homologous recombination deficiency: concepts, definitions, and assays","volume":"27","author":"Stewart","year":"2022","journal-title":"Oncologist"},{"key":"10.1016\/j.compbiolchem.2025.108471_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113993","article-title":"Disorders of cancer metabolism: the therapeutic potential of cannabinoids","volume":"157","author":"Sun","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib36","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41523-022-00411-3","article-title":"PARP inhibition in breast cancer: progress made and future hopes","volume":"8","author":"Tung","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.compbiolchem.2025.108471_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12040916","article-title":"The landscape of targeted therapies in TNBC","volume":"12","author":"Vagia","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.compbiolchem.2025.108471_bib39","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/03602532.2024.2405163","article-title":"Drug metabolism and transport mediated the hepatotoxicity of pleuropterus multiflorus root: a review","volume":"56","author":"Wu","year":"2024","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2022.122000","article-title":"Serum Raman spectroscopy combined with convolutional neural network for rapid diagnosis of HER2-positive and triple-negative breast cancer","volume":"286","author":"Zeng","year":"2023","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.compbiolchem.2025.108471_bib42","doi-asserted-by":"crossref","first-page":"33032","DOI":"10.1021\/acsnano.4c05693","article-title":"Multi targeted therapy for Alzheimer\u2019s disease by guanidinium-modified calixarene and cyclodextrin Co-assembly loaded with insulin","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.compbiolchem.2025.108471_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.119126","article-title":"Chrysotoxine regulates ferroptosis and the PI3K\/AKT\/mTOR pathway to prevent cervical cancer","volume":"338","author":"Zhou","year":"2025","journal-title":"J. Ethnopharmacol."}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927125001318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927125001318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:35:22Z","timestamp":1762547722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927125001318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":43,"alternative-id":["S1476927125001318"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108471","relation":{},"ISSN":["1476-9271"],"issn-type":[{"value":"1476-9271","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The drug discovery candidate for targeting PARP1 with Onosma. Dichroantha compounds in triple-negative breast cancer: A virtual screening and molecular dynamic simulation","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108471"}}